Risk factors for adverse outcomes at various phases of endoscopic ultrasound‐guided treatment of pancreatic fluid collections: Data from a multi‐institutional consortium
Digestive Endoscopy · 2024
DOI: 10.1111/den.14683 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Digestive Endoscopy, 2024. Verfasst von Tomotaka Saito und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Endosonography, Pancreatic Pseudocyst, Drainage. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japanese Foundation for Research and Promotion of Endoscopy.
Abstract (Originalsprache)
Objectives
No comprehensive study has examined short‐ and long‐term adverse outcomes of endoscopic ultrasound (EUS)‐guided treatment of pancreatic fluid collections (PFCs) including walled‐off necrosis (WON) and pseudocysts.
Methods
In a multi‐institutional cohort of 357 patients receiving EUS‐guided treatment of PFCs (228 with WON and 129 with pseudocysts), we examined PFC type‐specific risk factors for procedure‐related adverse events (AEs), clinical failure, and recurrence. Odds ratios (ORs) and hazard ratios (HRs) with 95% confidence intervals (CIs) were computed using the logistic and Cox regression models, respectively, adjusting for potential confounders.
Results
Adverse events were observed predominantly in WON, and risk factors were WON extension to the pelvis (OR 2.49; 95% CI 1.00–6.19) and endoscopic necrosectomy (OR 5.15; 95% CI 1.61–16.5). Risk factors for clinical failure in WON treatment included higher Charlson Comorbidity Index (OR for ≥3 vs. ≤2, 2.58; 95% CI 1.05–6.35), extension to the pelvis (OR 3.63; 95% CI 1.57–8.43), nonuse of a lumen‐apposing metal stent (OR 2.88; 95% CI 1.10–7.54), and percutaneous drainage (OR 3.73; 95% CI 1.27–10.9). Patients with pseudocysts extending to the paracolic gutter and the need for more than two endoscopic/percutaneous procedures had ORs for clinical failure of 5.28 (95% CI 1.10–25.3) and 5.52 (95% CI 1.61–18.9), respectively. Pseudocysts requiring the multigateway approach were associated with a high risk of recurrence (HR 4.00; 95% CI 1.11–11.6).
Conclusion
The adverse outcomes at various phases of EUS‐guided PFC treatment may be predictable based on clinical parameters. Further research is warranted to optimize treatment strategies for high‐risk patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
- Department of Gastroenterology and Hepatology, Faculty of Medicine, Kindai University, Osaka, Japan.
- Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Hyogo, Japan.
- Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
- Division of Gastroenterology and Hepatobiliary and Pancreatic Diseases, Department of Internal Medicine, Hyogo Medical University, Hyogo, Japan.
- Department of Gastroenterology, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
ORCID-Profile: Tomotaka Saito, Shunsuke Omoto, Mamoru Takenaka, Tsuyoshi Hamada, Hideyuki Shiomi, Toshio Fujisawa, Saburo Matsubara, Takuji Iwashita, Kensaku Yoshida, Mitsuru Okuno, Hiroyuki Isayama, Ichiro Yasuda, Yousuke Nakai
Förderung
- Japanese Foundation for Research and Promotion of Endoscopy
Zitieren
APA
Saito, T., Omoto, S., Takenaka, M., Tsujimae, M., Masuda, A., Sato, T., Hamada, T., Ota, S., Shiomi, H., Takahashi, S., Fujisawa, T., Nakagawa, K., Matsubara, S., Uemura, S., Iwashita, T., Yoshida, K., Maruta, A., Okuno, M., Iwata, K., …, & WONDERFUL study group in Japan (2024). Risk factors for adverse outcomes at various phases of endoscopic ultrasound‐guided treatment of pancreatic fluid collections: Data from a multi‐institutional consortium. Digestive Endoscopy. https://doi.org/10.1111/den.14683
Vancouver
Saito T, Omoto S, Takenaka M, Tsujimae M, Masuda A, Sato T, et al. Risk factors for adverse outcomes at various phases of endoscopic ultrasound‐guided treatment of pancreatic fluid collections: Data from a multi‐institutional consortium. Digestive Endoscopy. 2024. doi:10.1111/den.14683
BibTeX
@article{Saito2024,
author = {Saito, Tomotaka and Omoto, Shunsuke and Takenaka, Mamoru and Tsujimae, Masahiro and Masuda, Atsuhiro and Sato, Tatsuya and Hamada, Tsuyoshi and Ota, Shogo and Shiomi, Hideyuki and Takahashi, Sho and Fujisawa, Toshio and Nakagawa, Keito and Matsubara, Saburo and Uemura, Shinya and Iwashita, Takuji and Yoshida, Kensaku and Maruta, Akinori and Okuno, Mitsuru and Iwata, Keisuke and Hayashi, Nobuhiko and Mukai, Tsuyoshi and Isayama, Hiroyuki and Yasuda, Ichiro and Nakai, Yousuke and WONDERFUL study group in Japan, WONDERFUL study group in Japan},
title = {Risk factors for adverse outcomes at various phases of endoscopic ultrasound‐guided treatment of pancreatic fluid collections: Data from a multi‐institutional consortium},
journal = {Digestive Endoscopy},
year = {2024},
doi = {10.1111/den.14683}
}
EUVIMED